Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.
For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.
Key Takeaways
- Wall Street researchers just used Claude to design a drug.
- The experiment has spawned a new investment thesis..
- For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.
For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.
Read Complete Original Article
Published originally on MarketWatch Top Stories
Related News
Bull markets tend to peak with a whimper, not a bang — but a 15% correction for the S&P 500 may be next
Unlike bear-market bottoms, which typically end with a spasm of despair as traders throw in the towel, bull-market tops are far more gradual and less dramatic.
Stocks rise following strong profit reports from Equifax, Hasbro and others - Los Angeles Times
Stocks rise following strong profit reports from Equifax, Hasbro and others Los Angeles Times
Duos Technologies stock rises on 20 MW customer deal By Investing.com - Investing.com Australia
Duos Technologies stock rises on 20 MW customer deal By Investing.com Investing.com Australia
Capital One jumps 4% on better-than-expected Q3 results By Investing.com - Investing.com Australia
Capital One jumps 4% on better-than-expected Q3 results By Investing.com Investing.com Australia
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!
